145 related articles for article (PubMed ID: 23859156)
1. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.
Selting KA; Sharp CR; Ringold R; Knouse J
Vet Comp Oncol; 2015 Dec; 13(4):373-84. PubMed ID: 23859156
[TBL] [Abstract][Full Text] [Related]
2. Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.
Selting KA; Ringold R; Husbands B; Pithua PO
J Vet Intern Med; 2016 Jul; 30(4):1159-66. PubMed ID: 27214230
[TBL] [Abstract][Full Text] [Related]
3. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.
Grobman M; Outi H; Rindt H; Reinero C
J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921
[TBL] [Abstract][Full Text] [Related]
4. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
Sharif H; Hagman R; Wang L; Eriksson S
Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
[TBL] [Abstract][Full Text] [Related]
7. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the native C-reactive protein (cCRP) and the corresponding liver mRNA in dogs.
Jasensky AK; Bondzio A; Murugaiyan J; Siebert U; Roesler U; Kohn B; Einspanier R
Biochem Biophys Res Commun; 2014 Sep; 452(3):462-7. PubMed ID: 25159841
[TBL] [Abstract][Full Text] [Related]
9. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.
Kim Y; Park J; Kim B; Yu KR; Kim HS; Oh Y; Seo K; Ryu M; Park C; Bhang D; Choi U; Youn H
J Vet Intern Med; 2024; 38(1):300-307. PubMed ID: 38088206
[TBL] [Abstract][Full Text] [Related]
10. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.
von Euler H; Eriksson S
Vet Comp Oncol; 2011 Mar; 9(1):1-15. PubMed ID: 21303450
[TBL] [Abstract][Full Text] [Related]
11. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker.
Wang L; Sharif H; Saellström S; Rönnberg H; Eriksson S
BMC Vet Res; 2021 Sep; 17(1):316. PubMed ID: 34579716
[TBL] [Abstract][Full Text] [Related]
12. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of three different point-of-care tests for quantitative measurement of canine C-reactive protein.
Jasensky AK; Klenner S; Einspanier R; Kohn B
Vet Clin Pathol; 2015 Jun; 44(2):205-14. PubMed ID: 25962332
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a point-of-care benchtop analyzer for quantitative measurement of C-reactive protein in canine serum and plasma.
Connolly SL; Solter P; Don JH; Jeong KH; Constable PD
Vet Clin Pathol; 2022 Dec; 51(4):511-523. PubMed ID: 35578379
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a point-of-care test for canine C-reactive protein.
Plickert HD; Einspanier R; Arndt G; Brunnberg L; Kohn B
Vet Clin Pathol; 2011 Sep; 40(3):384-8. PubMed ID: 21827518
[TBL] [Abstract][Full Text] [Related]
16. Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.
Saellström S; Sharif H; Jagarlamudi KK; Rönnberg H; Wang L; Eriksson S
Res Vet Sci; 2022 Jul; 145():213-221. PubMed ID: 35245727
[TBL] [Abstract][Full Text] [Related]
17. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
[TBL] [Abstract][Full Text] [Related]
18. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
19. Iron status and C-reactive protein in canine leishmaniasis.
Silvestrini P; Zoia A; Planellas M; Roura X; Pastor J; Cerón JJ; Caldin M
J Small Anim Pract; 2014 Feb; 55(2):95-101. PubMed ID: 24372300
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Randox and Fuji Dri-Chem vcCRP-P assays of canine C-reactive protein.
An SA; Oh YI; Choi US; Lee JB; Seo KW
J Vet Diagn Invest; 2022 Sep; 34(5):842-847. PubMed ID: 35792552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
